Global Fatty Liver Treatment Market Research Report 2023

Report ID: 1993293 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Fatty Liver Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Thiazolidinedione
        1.2.3 Vitamin E
        1.2.4 Metformin Statins
        1.2.5 Polyunsaturated Fatty Acids
        1.2.6 Angiotensin Receptor Blockers
        1.2.7 Pentoxifylline
    1.3 Market by Application
        1.3.1 Global Fatty Liver Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals and Clinics
        1.3.3 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Fatty Liver Treatment Market Perspective (2017-2028)
    2.2 Fatty Liver Treatment Growth Trends by Region
        2.2.1 Fatty Liver Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Fatty Liver Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Fatty Liver Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Fatty Liver Treatment Market Dynamics
        2.3.1 Fatty Liver Treatment Industry Trends
        2.3.2 Fatty Liver Treatment Market Drivers
        2.3.3 Fatty Liver Treatment Market Challenges
        2.3.4 Fatty Liver Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Fatty Liver Treatment Players by Revenue
        3.1.1 Global Top Fatty Liver Treatment Players by Revenue (2017-2022)
        3.1.2 Global Fatty Liver Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Fatty Liver Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Fatty Liver Treatment Revenue
    3.4 Global Fatty Liver Treatment Market Concentration Ratio
        3.4.1 Global Fatty Liver Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Treatment Revenue in 2021
    3.5 Fatty Liver Treatment Key Players Head office and Area Served
    3.6 Key Players Fatty Liver Treatment Product Solution and Service
    3.7 Date of Enter into Fatty Liver Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Liver Treatment Breakdown Data by Type
    4.1 Global Fatty Liver Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Fatty Liver Treatment Forecasted Market Size by Type (2023-2028)
5 Fatty Liver Treatment Breakdown Data by Application
    5.1 Global Fatty Liver Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Fatty Liver Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Fatty Liver Treatment Market Size (2017-2028)
    6.2 North America Fatty Liver Treatment Market Size by Country (2017-2022)
    6.3 North America Fatty Liver Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Fatty Liver Treatment Market Size (2017-2028)
    7.2 Europe Fatty Liver Treatment Market Size by Country (2017-2022)
    7.3 Europe Fatty Liver Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Fatty Liver Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Fatty Liver Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Fatty Liver Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Fatty Liver Treatment Market Size (2017-2028)
    9.2 Latin America Fatty Liver Treatment Market Size by Country (2017-2022)
    9.3 Latin America Fatty Liver Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Fatty Liver Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Fatty Liver Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Fatty Liver Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Cardax
        11.1.1 Cardax Company Detail
        11.1.2 Cardax Business Overview
        11.1.3 Cardax Fatty Liver Treatment Introduction
        11.1.4 Cardax Revenue in Fatty Liver Treatment Business (2017-2022)
        11.1.5 Cardax Recent Development
    11.2 Daewoong
        11.2.1 Daewoong Company Detail
        11.2.2 Daewoong Business Overview
        11.2.3 Daewoong Fatty Liver Treatment Introduction
        11.2.4 Daewoong Revenue in Fatty Liver Treatment Business (2017-2022)
        11.2.5 Daewoong Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Fatty Liver Treatment Introduction
        11.3.4 Roche Revenue in Fatty Liver Treatment Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Glenmark
        11.4.1 Glenmark Company Detail
        11.4.2 Glenmark Business Overview
        11.4.3 Glenmark Fatty Liver Treatment Introduction
        11.4.4 Glenmark Revenue in Fatty Liver Treatment Business (2017-2022)
        11.4.5 Glenmark Recent Development
    11.5 GW
        11.5.1 GW Company Detail
        11.5.2 GW Business Overview
        11.5.3 GW Fatty Liver Treatment Introduction
        11.5.4 GW Revenue in Fatty Liver Treatment Business (2017-2022)
        11.5.5 GW Recent Development
    11.6 Limerick BioPharma
        11.6.1 Limerick BioPharma Company Detail
        11.6.2 Limerick BioPharma Business Overview
        11.6.3 Limerick BioPharma Fatty Liver Treatment Introduction
        11.6.4 Limerick BioPharma Revenue in Fatty Liver Treatment Business (2017-2022)
        11.6.5 Limerick BioPharma Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Fatty Liver Treatment Introduction
        11.7.4 Merck Revenue in Fatty Liver Treatment Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Fatty Liver Treatment Introduction
        11.8.4 Novartis Revenue in Fatty Liver Treatment Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Orchid
        11.9.1 Orchid Company Detail
        11.9.2 Orchid Business Overview
        11.9.3 Orchid Fatty Liver Treatment Introduction
        11.9.4 Orchid Revenue in Fatty Liver Treatment Business (2017-2022)
        11.9.5 Orchid Recent Development
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Detail
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Fatty Liver Treatment Introduction
        11.10.4 AstraZeneca Revenue in Fatty Liver Treatment Business (2017-2022)
        11.10.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Fatty Liver Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Thiazolidinedione
    Table 3. Key Players of Vitamin E
    Table 4. Key Players of Metformin Statins
    Table 5. Key Players of Polyunsaturated Fatty Acids
    Table 6. Key Players of Angiotensin Receptor Blockers
    Table 7. Key Players of Pentoxifylline
    Table 8. Global Fatty Liver Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Fatty Liver Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Fatty Liver Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Fatty Liver Treatment Market Share by Region (2017-2022)
    Table 12. Global Fatty Liver Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Fatty Liver Treatment Market Share by Region (2023-2028)
    Table 14. Fatty Liver Treatment Market Trends
    Table 15. Fatty Liver Treatment Market Drivers
    Table 16. Fatty Liver Treatment Market Challenges
    Table 17. Fatty Liver Treatment Market Restraints
    Table 18. Global Fatty Liver Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Fatty Liver Treatment Market Share by Players (2017-2022)
    Table 20. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Treatment as of 2021)
    Table 21. Ranking of Global Top Fatty Liver Treatment Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Fatty Liver Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Fatty Liver Treatment Product Solution and Service
    Table 25. Date of Enter into Fatty Liver Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Fatty Liver Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Fatty Liver Treatment Revenue Market Share by Type (2017-2022)
    Table 29. Global Fatty Liver Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Fatty Liver Treatment Revenue Market Share by Type (2023-2028)
    Table 31. Global Fatty Liver Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Fatty Liver Treatment Revenue Market Share by Application (2017-2022)
    Table 33. Global Fatty Liver Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Fatty Liver Treatment Revenue Market Share by Application (2023-2028)
    Table 35. North America Fatty Liver Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Fatty Liver Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Fatty Liver Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Fatty Liver Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Fatty Liver Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Fatty Liver Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Fatty Liver Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Fatty Liver Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Fatty Liver Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Fatty Liver Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Cardax Company Detail
    Table 46. Cardax Business Overview
    Table 47. Cardax Fatty Liver Treatment Product
    Table 48. Cardax Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 49. Cardax Recent Development
    Table 50. Daewoong Company Detail
    Table 51. Daewoong Business Overview
    Table 52. Daewoong Fatty Liver Treatment Product
    Table 53. Daewoong Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 54. Daewoong Recent Development
    Table 55. Roche Company Detail
    Table 56. Roche Business Overview
    Table 57. Roche Fatty Liver Treatment Product
    Table 58. Roche Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 59. Roche Recent Development
    Table 60. Glenmark Company Detail
    Table 61. Glenmark Business Overview
    Table 62. Glenmark Fatty Liver Treatment Product
    Table 63. Glenmark Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 64. Glenmark Recent Development
    Table 65. GW Company Detail
    Table 66. GW Business Overview
    Table 67. GW Fatty Liver Treatment Product
    Table 68. GW Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 69. GW Recent Development
    Table 70. Limerick BioPharma Company Detail
    Table 71. Limerick BioPharma Business Overview
    Table 72. Limerick BioPharma Fatty Liver Treatment Product
    Table 73. Limerick BioPharma Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 74. Limerick BioPharma Recent Development
    Table 75. Merck Company Detail
    Table 76. Merck Business Overview
    Table 77. Merck Fatty Liver Treatment Product
    Table 78. Merck Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. Novartis Company Detail
    Table 81. Novartis Business Overview
    Table 82. Novartis Fatty Liver Treatment Product
    Table 83. Novartis Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 84. Novartis Recent Development
    Table 85. Orchid Company Detail
    Table 86. Orchid Business Overview
    Table 87. Orchid Fatty Liver Treatment Product
    Table 88. Orchid Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 89. Orchid Recent Development
    Table 90. AstraZeneca Company Detail
    Table 91. AstraZeneca Business Overview
    Table 92. AstraZeneca Fatty Liver Treatment Product
    Table 93. AstraZeneca Revenue in Fatty Liver Treatment Business (2017-2022) & (US$ Million)
    Table 94. AstraZeneca Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fatty Liver Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Thiazolidinedione Features
    Figure 3. Vitamin E Features
    Figure 4. Metformin Statins Features
    Figure 5. Polyunsaturated Fatty Acids Features
    Figure 6. Angiotensin Receptor Blockers Features
    Figure 7. Pentoxifylline Features
    Figure 8. Global Fatty Liver Treatment Market Share by Application in 2021 & 2028
    Figure 9. Hospitals and Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Fatty Liver Treatment Report Years Considered
    Figure 12. Global Fatty Liver Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Fatty Liver Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Fatty Liver Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Fatty Liver Treatment Market Share by Players in 2021
    Figure 16. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Fatty Liver Treatment Revenue in 2021
    Figure 18. North America Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Fatty Liver Treatment Market Share by Country (2017-2028)
    Figure 20. United States Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Fatty Liver Treatment Market Share by Country (2017-2028)
    Figure 24. Germany Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Fatty Liver Treatment Market Share by Region (2017-2028)
    Figure 32. China Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Fatty Liver Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Fatty Liver Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Fatty Liver Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Cardax Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 47. Daewoong Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 49. Glenmark Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 50. GW Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 51. Limerick BioPharma Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 52. Merck Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 53. Novartis Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 54. Orchid Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 55. AstraZeneca Revenue Growth Rate in Fatty Liver Treatment Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid
AstraZeneca
Frequently Asked Questions
Fatty Liver Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Fatty Liver Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Fatty Liver Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

FinTech

FinTech market is segmented by players, region (country), by Type and by Application. Players, st ... Read More